Bioventix PLC (BVXP.L) LSE
1,660.00
+0(+0.00%)
Currency In GBp
- General
- Statistics
- Historical Data
- Profile
- Financials
1,660.00
+0(+0.00%)
Currency In GBp
Address
27–28 Eastcastle Street
Farnham, W1W 8DH
United Kingdom of Great Britain and Northern Ireland (the)
Phone
441252728001
Website
Sector
Healthcare
Industry
Biotechnology
Employees
17
First IPO Date
April 29, 2014
| Name | Title | Pay | Year Born |
| Peter John Harrison | Chief Executive Officer & Director | 362,343 | 1958 |
| Bruce Edward Heath Hiscock | Chief Financial Officer & Director | 105,844 | 1958 |
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, infectious disease, oncology, and miscellaneous indications. It also provides contract SMAs and recombinant services. Bioventix PLC was incorporated in 2003 and is based in London, the United Kingdom.